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a b s t r a c t
At early times in Mammalian Orthoreovirus (MRV) infection, cytoplasmic inclusions termed stress
granules (SGs) are formed as a component of the innate immune response, however, at later times they
are no longer present despite continued immune signaling. To investigate the roles of MRV proteins in SG
modulation we examined non-structural protein mNS localization relative to SGs in infected and
transfected cells. Using a series of mutant plasmids, we mapped the necessary μNS residues for SG
localization to amino acids 78 and 79. We examined the capacity of a μNS(78–79) mutant to associate
with known viral protein binding partners of μNS and found that it loses association with viral core
protein λ2. Finally, we show that while this mutant cannot support de novo viral replication, it is able to
rescue replication following siRNA knockdown of μNS. These data suggest that μNS association with SGs,
λ2, or both play roles in MRV replication.
& 2013 Elsevier Inc. All rights reserved.
Introduction
Mammalian Orthoreovirus (MRV) is a member of the dsRNA
family Reoviridae that contains a number of viruses that are
important in human, animal, and plant health. In mammals, these
viruses can cause respiratory or gastrointestinal illness which in some
cases (e.g., Rotavirus, Bluetongue virus), can lead to host death
(Parashar et al., 2009; Schwartz-Cornil et al., 2008). In contrast, MRV
is non-pathogenic in humans and most animals and therefore lends
itself to being a safe research vehicle for determining the nuances of
viral replication in a host organism. To initiate infection MRV particles
bind to their primary and secondary receptors, JAM-1 and sialic acid
respectively, via the cell attachment protein s1 and enter the cell by
receptor mediated endocytosis (Barton et al., 2001; Chappell et al.,
1997). Once in the endosome intermediate subvirion particles (ISVPs)
are formed via cathepsin protease cleavage of capsid protein s3,
resulting in exposure of the previously shielded MRV membrane
penetration protein μ1 (Ebert et al., 2002). Proteolytic cleavage
and conformational reorganization of μ1 facilitates movement of
transcriptionally active core particles across the endosomal membrane
into the cytoplasm (Agosto et al., 2006; Chandran et al., 2002; Nibert
and Fields, 1992; Zhang et al., 2006). Once in the cytoplasm viral
positive sense RNAs are transcribed from within the core particle and
are released to be synthesized into protein by the cellular translational
machinery (Shatkin and Both, 1976; Tao et al., 2002).
Early in MRV infection viral factories (VFs) form as small
punctate structures throughout the cytoplasm that grow in size
and become more perinuclear as infection continues (Rhim et al.,
1962). The structural matrix of VFs appears to be primarily formed
by the MRV non-structural protein mNS, which, when expressed in
the absence of other virus proteins, forms virus factory like (VFL)
structures in cells (Broering et al., 2002; Mora et al., 1987). mNS is a
721 amino acid, primarily α-helical protein encoded by the M3
MRV gene segment that has been shown to interact with most
other MRV proteins and virus core particles (Broering et al., 2004,
2002; McCutcheon et al., 1999; Miller et al., 2010, 2003). These
associations are likely to be important in recruiting newly synthe-
sized proteins to the VFs to allow for the efﬁcient assembly of
progeny virus core particles. VFs are dynamic structures that are
thought to be the primary location of virus transcription, replica-
tion, and assembly and recent studies have shown that the
formation of VFs is necessary for successful MRV infection
(Arnold et al., 2008; Becker et al., 2003; Broering et al., 2000;
Dales, 1965; Kobayashi et al., 2009).
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When MRV enters a host cell the innate immune response is
activated via PKR, resulting in phosphorylation of eIF2α and
shutoff of host translation (Pain, 1996; Samuel et al., 1984; Smith
et al., 2005; Zweerink and Joklik, 1970). While some MRV strains
are able to prevent this shutoff via the dsRNA binding activity of
the viral s3 protein, other MRV strains are unable to inhibit host
translational shutoff following infection (Imani and Jacobs, 1988;
Schmechel et al., 1997; Smith et al., 2005; Yue and Shatkin, 1997).
Concurrent with translational inhibition, important translational
factors are sequestered into cytoplasmic bodies termed stress
granules (SGs). SGs form following eIF2α phosphorylation and
other perturbations of translation initiation that lead to the
accumulation of stalled ribosomal complexes in the cell
(Anderson and Kedersha, 2002; Dang et al., 2006; Kedersha and
Anderson, 2002; Kim et al., 2007; Mazroui et al., 2006; Mokas
et al., 2009). SGs appear as globular structures throughout the
cytoplasm and consist of an accumulation of cellular proteins such
as T-cell restricted antigen-1 (TIA-1), TIA-1 related (TIAR), and
GTPase-activating protein binding protein-1 (G3BP), translation
initiation factors, translationally silent mRNAs, and small, but not
large, ribosomal subunits (Gilks et al., 2004; Tourriere et al., 2003).
SGs have previously been found in MRV infected cells following
virus-induced eIF2α phosphorylation (Qin et al., 2009; Smith et al.,
2006). Despite sustained levels of eIF2α phosphorylation, SGs
appear to be disrupted at later times in infection. This disruption
of SGs correlates with the escape of viral, but not cellular, mRNAs
from host translational shutoff (Qin et al., 2011). As the ability to
overcome translational shutoff is critical for continued viral
replication, describing the mechanism of MRV modulation of SGs
is likely to be an important step in understanding the virus' ability
to circumvent the cellular stress response.
Although many aspects of SG formation and function are not
fully understood, it is believed that they may serve as a component
of the innate immune response to infection by many viruses
(Lloyd, 2012; Onomoto et al., 2012). Viruses such as poliovirus,
inﬂuenza A virus, and hepatitis C virus are also known to modulate
SGs upon infection. These viruses have devised strategies to
circumvent the loss of cellular translational machinery to SGs.
These strategies range from preventing the formation of SGs to
disrupting SGs to allow for successful replication (Garaigorta et al.,
2012; Khaperskyy et al., 2012; White et al., 2007; White and Lloyd,
2011; Yi et al., 2011). Other viruses like respiratory syncytial virus
and vaccinia virus appear to take advantage of SGs to enhance
their replication (Katsafanas and Moss, 2007; Lindquist et al.,
2010). While SG formation and disruption during MRV infection
is well-established, the mechanisms involved and role played by
MRV in the process have not been determined.
To further investigate SG modulation during MRV infection we
examined the localization of each virus protein relative to SGs in
both infected and transfected cells. Several MRV proteins, includ-
ing mNS, appeared to localize to SGs. We hypothesized that μNS,
via its association with SGs and other virus proteins, may serve as
Fig. 1. mNS localizes with but does not induce or disrupt SGs. (A) Cos-7 cells were infected and at 6 h p.i. were ﬁxed and immunostained with rabbit α-mNS polyclonal
antiserum (left column) and goat α-TIAR polyclonal antibody (middle column) followed by Alexa-594 conjugated donkey α-rabbit IgG and Alexa-488 conjugated donkey
α-goat IgG. Merged images containing DAPI-stained nuclei (blue) are shown (right column). (B) Cos-7 cells were transfected with pCI–mNS and at 24 h p.t. were ﬁxed
and immunostained (top row) or treated with 0.5 mM SA for 1 h (bottom row) at 23 h, ﬁxed, and immunostained as in (A). mNS WT¼wild type, bar¼10 mm.
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Fig. 2. mNS amino acids 76–85 are important for localization to SGs. (A) Illustration of plasmids used in mapping the mNS residues necessary for SG localization. Not to scale.
(B) Cos-7 cells were transfected with pCI–mNS (ﬁrst row), pCI–mNS(55–721) (second row), pCI–mNS(65–721) (third row), pCI–mNS(75–721) (fourth row), pCI–mNS(85–721)
(ﬁfth row), and pCI–mNS(95–721) (sixth row) and at 23 h p.t. were treated with 0.5 mM SA for 1 h, ﬁxed, and immunostained with rabbit α-mNS polyclonal antiserum (left
column) and goat α-TIAR polyclonal antibody (middle column) followed by Alexa-594 conjugated donkey α-rabbit IgG and Alexa-488 conjugated donkey α-goat IgG. Merged
images containing DAPI-stained nuclei (blue) are shown (right column). mNS WT¼wild type, bar¼10 mm.
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a nucleating factor for localization of other virus proteins to SGs.
Moreover, because μNS VFLs have been shown to require an
intact cellular microtubule network (which is also necessary for
SG formation) for coalescence into larger VFL structures and
movement to perinuclear regions of the cell (Broering et al.,
2002), we also hypothesized that μNS may utilize the micro-
tubule machinery to associate with SGs or usurp the microtubule
machinery and prevent SG formation during MRV infection.
Utilizing deletion and point mutations we mapped the interac-
tion between mNS and SGs and identiﬁed a two amino acid region
within the amino (N)-terminal third of mNS necessary for SG
localization. We additionally examined the impact of this muta-
tion on previously identiﬁed interactions between mNS and other
viral proteins. Finally, we examined the effect of this mutation on
virus replication.
Results
μNS colocalizes with SGs in infected and transfected cells but does not
modulate SG formation
In an effort to determine the mechanism of SG modulation in
MRV infection we examined the localization of MRV proteins
relative to virus-induced SGs in infected cells. We have previously
shown that MRV induces SGs at early times (4–6 h post infection,
p.i.) in infection (Qin et al., 2009), therefore, Cos-7 cells were
infected with MRV T3D and at 6 h p.i. cells were ﬁxed and stained
with antibodies against individual virus proteins and the SG-
localized protein TIAR. Several viral proteins showed some locali-
zation to SGs, including the non-structural mNS protein (Fig. 1A
and data not shown). Localization of μNS to SGs was also observed
in cells infected with MRV strain T1L (data not shown).
To determine if mNS had the capacity to induce SGs indepen-
dently of infection Cos-7 cells were transfected with a plasmid
expressing wild type mNS (pCI–mNS). At 24 h post-transfection (p.
t.) cells were immunostained with antibodies against mNS and the
SG localized protein TIAR (Fig. 1B, top row). In these cells mNS
formed the previously described VFL structures (Becker et al.,
2003; Broering et al., 2002) whereas TIAR was diffusely distributed
throughout the cells and SGs were not present. This data indicates
that mNS is not capable of inducing SGs independently of virus
infection and further, because TIAR did not localize to VFLs, that
the association between mNS and SGs seen in infected cells does
not likely occur through the TIAR protein. Similar results were
seen in cells expressing mNS that were immunostained with
antibodies against other known SG-localized proteins TIA-1 and
G3BP (data not shown).
Although MRV induces SGs at early times in infection, we have
previously shown that at late times in infection SGs are not
present even though eIF2α is phosphorylated (Qin et al., 2011).
Moreover, we found that at late times in infection MRV is able to
prevent SG formation in cells treated with external stressors such
as sodium arsenite (SA) which induces eIF2α phosphorylation
through the Heme Regulated Inhibitor (HRI) kinase (McEwen et al.,
2005). To ascertain whether mNS can disrupt SGs induced by SA,
Cos-7 cells were transfected with pCI–mNS and at 23 h p.t. SA was
added for 1 h to induce SGs, after which cells were ﬁxed and
immunostained with antibodies against mNS and TIAR (Fig. 1B,
bottom row). In these experiments SGs were clearly formed as a
result of SA treatment in cells expressing mNS, suggesting that mNS
is unable to independently prevent SG formation in the absence of
infection. However, in these cells, mNS partially colocalized with
Fig. 3. mNS amino acids 78 and 79 are necessary for localization to SGs. (A) Illustration
of plasmids used in mapping the mNS residues necessary for SG localization. Not to
scale. (B–D) Cos-7 cells were transfectedwith (B) pT7–mNS(76–79)RZ (top) or pT7–mNS
(80–84)RZ (bottom), (C) pT7–mNS(76–77)RZ (top), pT7–mNS(78–79)RZ (middle) or
pT7-μNS (78–79, VR-LK)RZ (bottom), (D) pT7–mNS(78)RZ (top) or pT7–mNS(79)RZ
(bottom) and at 23 h p.t. were treated with 0.5 mM SA for 1 h, ﬁxed, and immunos-
tained with rabbit α-mNS polyclonal antiserum (left column) and goat α-TIAR
polyclonal antibody (middle column) followed by Alexa-594 conjugated donkey α-
rabbit IgG and Alexa-488 conjugated donkey α-goat IgG. Merged images containing
DAPI-stained nuclei (blue) are shown (right column). Bar¼10 mm.
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SGs induced by SA with strong mNS staining in every SG as well as
some mNS staining in VFLs that did not stain with TIAR. This
pattern of localization suggests that upon SG formation a portion
of mNS is recruited to SGs while a separate portion of mNS remains
associated with VFL structures. Altogether these data suggest that
mNS localizes to SGs in both infected and transfected cells,
however, it is not solely responsible for the induction or disruption
of SGs seen in MRV infected cells.
Fig. 4. mNS(78–79) is not highly ubiquitinated or unstable. Cos-7 cells were transfected with pCI–mNS or pT7–mNS(78–79)RZ. (A) At 24 h p.t. cells were ﬁxed and
immunostained with rabbit α-mNS polyclonal antiserum (left column) and mouse monoclonal α-multi-ubiquitin antibody (middle column) followed by Alexa-594 conjugated
donkey α-rabbit IgG and Alexa-488 conjugated donkey α-mouse IgG. Merged images containing DAPI-stained nuclei (blue) are shown (right column). Bar¼10 mm. (B) At 24 h
p.t. cells were treated with cycloheximide (100 μg/ml). Proteins were harvested at indicated times post-drug addition and immunoblotted with μNS and β-actin antibodies.
(C) μNS levels were normalized to β-actin and numbers relative to time zero from 5 replicates with standard error of the averages are shown.
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μNS amino acids 76–85 are required for association with SGs.
In order to identify the region of mNS responsible for localiza-
tion with SGs, a series of deletion mutant plasmids in which 10
amino acid sections were progressively deleted from the mNS
N-terminus were utilized (Miller et al., 2010) (Fig. 2A). Cos-7 cells
were transfected with the N-terminal deletion plasmids and at
23 h p.t. SGs were induced with SA, and mNS localization relative
to SGs was determined by immunostaining with antibodies
against mNS and TIAR (Fig. 2B). In these experiments the interac-
tion between mNS and SGs was maintained in all of the mutants
up to the point where 75 amino-acids were deleted from the
N-terminus [pCI–mNS(55–721), pCI–mNS(65–721), and pCI–mNS
(75–721)], whereas those in which 76 or more amino-acids were
deleted from the N-terminus lost localization with SGs [pCI–mNS
(85–721) and pCI–mNS(95–721)]. The maintenance and loss of
localization with SGs of these mutants suggests that mNS amino-
acids 76–85 are necessary for mNS recruitment to SGs.
mNS amino-acids 78–79 are necessary for mNS localization to SGs
To further narrow the 10 amino acid region identiﬁed as being
important in mNS association with SGs, two point mutants were
constructed in which either mNS amino acids 76–79 or 80–84 were
mutated such that they encoded glycines/alanines in those four or
ﬁve positions (Fig. 3A). Plasmids expressing these mutants (pT7–m
NS(76–79)RZ and pT7–mNS(80–84)RZ) were transfected in Cos-7
cells and at 23 h p.t. SGs were induced with SA and localization of
mNS was examined by immunostaining using antibodies against
mNS and TIAR. In these experiments mNS(76–79) showed both TIAR
stained SGs and mNS stained VFLs, however, the two cytoplasmic
structures did not overlap, suggesting a distinct loss of mNS
localization to SGs (Fig. 3B, top row). mNS(80–84) on the other
hand presented a similar pattern of localization as seen in wild
type mNS, with clearly overlapping mNS and TIAR signals in all SG
structures and some mNS in VFLs that did not overlap with SGs
(Fig. 3B, bottom row). The absence of mNS localization to SGs in the
mNS(76–79) mutant indicates that the amino acids responsible for
mNS localization to SGs are found between residues 76 and 79.
To continue narrowing down the necessary amino acids resi-
dues for mNS localization to SGs, the previously identiﬁed four
amino acid section was further split into two amino acid point
mutants in which the native amino acids present in mNS at
positions 76–77 or 78–79 were changed to glycine or alanine
[pT7–mNS(76–77)RZ and pT7–mNS(78–79)RZ, Fig. 3A]. Cos-7 cells
were transfected with these plasmids and at 23 h p.t. cells were
treated with SA for 1 h, at which point cells were ﬁxed and
immunostained with antibodies against mNS and TIAR. The mNS
(76–77) mutant exhibited a pattern of localization with SGs that
was similar to wild-type mNS, suggesting these residues were not
involved in mNS localization to SGs (Fig. 3C, top row), however,
though both SGs and VFLs were present in cells expressing mNS
(78–79) (Fig. 3C, middle row) they did not overlap, suggesting that
mNS residues 78–79 are necessary for mNS localization to SGs.
To further explore the role of μNS amino acids 78–79 in
association with SGs, an additional mutant was created in which
the valine and arginine residues at these positions were changed
to the highly conserved amino-acid residues leucine and lysine
[pT7μNS(78–79, VR-LK)RZ]. Cos-7 cells were transfected with
this plasmid and at 23 h p.t. cells were treated with SA for 1 h,
at which point cells were ﬁxed and immunostained with anti-
bodies against mNS and TIAR. While mNS(78–79, VR-LK) did not
exhibit the complete loss of association with SGs seen in the
original μNS(78–79) mutant, μNS association with SGs in these
cells was visibly diminished relative to wildtype μNS (Fig. 3C,
bottom row), further suggesting that μNS amino-acids 78–79 are
necessary for maximum association between μNS and SGs.
To determine the individual contribution of amino acids 78 and
79 in mNS and SG localization, two plasmids containing single
point mutations in either amino acid were constructed (pT7–mNS
(78)RZ and pT7–mNS(79)RZ, Fig. 3A) and mNS localization relative
to SGs was examined following transfection. In these experiments,
though the mNS association with SGs again appeared qualitatively
weaker than that seen with wildtype μNS, both the mNS(78) and
mNS(79) mutants showed some localization with SGs (Fig. 3D).
These data indicate that mutation of amino acids 78 or 79
individually does not fully disrupt mNS localization to SGs, suggest-
ing that mutation of both amino acids to non-conserved amino-
acids is necessary to fully disrupt this localization. It should be
noted that all of the above substitution mutations resulted in a
μNS phenotype with delayed VFL formation and, at the time of IFA,
the VFLs in these mutants appeared qualitatively smaller than
those typically seen in cells expressing wildtype μNS. Experiments
performed at later times post-transfection indicated that the
mutant μNS proteins were able to form larger VFLs over time
(data not shown). Differences in VFL size did not appear to impact
μNS association with SGs as both SG-interacting [mNS(76–77)] and
non SG-interacting mNS [mNS(78–79)] displayed the delayed VFL
formation phenotype.
mNS(78–79) is not unstable or highly ubiquitinated
Creation of any mutation within a protein carries the possibility
of inducing changes that result in misfolding, aggregation, ubiqui-
tination, instability, and loss of protein function. To assess this
possibility with mNS(78–79), we ﬁrst examined ubiquitination of
the protein by immunoﬂuorescence assay. Cos-7 cells were trans-
fected with either pCI–mNS or pT7–mNS(78–79)RZ and at 24 h p.t.
were ﬁxed and immunostained with antibodies against mNS and
multi-ubiquitin. As has been previously reported, wild type mNS
did not substantially colocalize with ubiquitin in these experi-
ments, suggesting the protein is not misfolded (Broering et al.,
2005) (Fig. 4A, top row). Similar to wild type mNS, there did not
appear to be any colocalization between ubiquitin and mNS(78–79)
(Fig. 4A, bottom row), suggesting that introduction of glycine and
alanine at amino acids 78 and 79 does not lead to substantial
protein misfolding or ubiquitination.
We additionally examined the stability of mNS(78–79) relative
to wildtype mNS. Cos-7 cells were transfected with either pCI–mNS
or pT7–mNS(78–79)RZ and at 24 h p.t, cells were treated with
cycloheximide to inhibit further protein translation. At 0, 4, 8, and
24 h post drug-treatment, cells were harvested and protein sam-
ples were separated on SDS-PAGE, transferred to nitrocellulose,
and immunoblotted with antibodies against mNS or β-actin
(Fig. 4B). Although there was a consistent decrease in overall
protein expression in the mNS(78–79)RZ samples relative to wild-
type μNS, there was no statistical difference in degradation rates
over multiple experiments between the mutant and wildtype
proteins (Fig. 4C), strongly suggesting that these mutations at
μNS amino-acids 78–79 are not resulting in enhanced protein
misfolding, ubiquitination, or degradation of the protein.
mNS(78–79) maintains association with virus proteins sNS, s2, μ2
and λ1
A second test of functionality of a mutated protein is determin-
ing whether known roles of the protein are still active. Previous
work has shown that in addition to forming the structural matrix
of VFs, mNS interacts with many other MRV proteins and recruits or
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Fig. 5. mNS(78–79) maintains interaction with sNS, m2, s2, and λ1. Cos-7 cells were co-transfected with pCI–mNS (top) or pT7–mNS(78–79)RZ (bottom) and (A) pCI–sNS, (B)
pCI–m2, (C) pCI–s2, or (D) pCI–λ1 and at 24 h p.t. were ﬁxed and immunostained with mouse polyclonal antiserum against mNS (left column) and rabbit polyclonal antiserum
against sNS, m2, or MRV-cores (middle column) followed by Alexa-594 conjugated donkey α-mouse IgG and Alexa-488 conjugated donkey α-rabbit IgG. Merged images
containing DAPI-stained nuclei (blue) are shown (right column). Bar¼10 mm.
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retains them in VFLs when both proteins are expressed in cells. In
the case of the microtubule associated μ2 protein, instead of being
retained in μNS-formed VFLs, mNS associates with μ2 on micro-
tubules when both proteins are expressed in cells (Broering et al.,
2004, 2002; Miller et al., 2010, 2003). The virus proteins that mNS
has been shown to interact with include the non-structural sNS
protein as well as the core proteins, μ2, λ1, λ2, λ3, and s2. The
interaction sites of all of these proteins have been mapped and
several of them (sNS, μ2, λ1, and s2) occur within the N-terminal
third of mNS but do not directly overlap with mNS amino-acids
78–79 (Miller et al., 2010). As we were interested in examining the
role of the mNS interaction with SGs during virus infection using
the mNS(78–79) mutant, this overlap represented a potential
problem in that the mutation of amino acids 78–79 could interrupt
those interactions. To determine if this was the case, pT7–mNS(78–
79)RZ or pCI–mNS were each cotransfected into Cos-7 cells with
plasmids expressing sNS, s2, m2, or λ1 and at 24 h p.t. cells were
ﬁxed and immunostained with antibodies against mNS and each of
the virus proteins to determine whether the interaction between
mNS(78–79) and each protein was maintained. In each case the
expressed virus protein was colocalized with both wild type mNS
and mNS(78–79), suggesting that the proteins maintained interac-
tion with the mutant mNS (Fig. 5A–D). The maintenance of these
associations additionally suggests that the mutant protein main-
tains proper folding in order to sustain these interactions.
Mutation of mNS amino acids 78–79 disrupts mNS association with λ2
Like sNS, s2, m2, and λ1, core surface protein λ2 is also known
to interact with mNS via its N terminal end, however, the interac-
tion of λ2 protein is of particular interest because it has been
shown that mNS amino acids 76–85 are necessary for this interac-
tion, suggesting an increased possibility that the site we identiﬁed
as being necessary for mNS localization to SGs may overlap with
the λ2 association site (Miller et al., 2010). To determine the
impact of mutating mNS amino acids 78–79 on its interaction
with λ2, pCI–mNS or pT7-mNS(78–79)RZ were cotransfected with
pCI–λ2 into Cos-7 cells and at 24 h p.t. cells were immunostained
with antibodies against mNS and λ2. In these experiments, unlike
the λ2 colocalization with wild-type mNS in VFLs (Fig. 6, top row),
in cells expressing mNS(78–79), λ2 did not localize to VFLs and was
instead diffusely distributed throughout the transfected cells
(Fig. 6, bottom row). These ﬁndings suggest that in addition to
being involved in mNS localization to SGs, mNS residues 78–79 are
required for association with λ2.
mNS(78–79) is non-functional in rescue of recombinant virus using
reverse genetics
To determine the viability of a virus containing a mutation
within mNS amino-acids 78–79, a previously described four
plasmid-based reverse genetics system was utilized in attempts
to create recombinant virus (Boehme et al., 2011; Kobayashi et al.,
2010). In an effort to increase efﬁciency of plasmid uptake and
mimic the conditions used in wild type controls, the mNS(78–79)
mutation was subcloned out of the pT7–mNS(78–79)RZ plasmid
into the reverse genetics plasmid pT7–L2–M3T1L so that a total of
Fig. 6. mNS(78–79) does not associate with λ2. Cos-7 cells were co-transfected with pCI–mNS (top) or pT7–mNS(78–79)RZ (bottom) and pCI–λ2. At 24 h p.t. cells were ﬁxed
and immunostained with rabbit α-mNS polyclonal antiserum (left column) and mouse monoclonal antibody (7F4) against λ2 (middle column) followed by Alexa-594
conjugated donkey α-rabbit IgG and Alexa-488 conjugated donkey α-mouse IgG. Merged images containing DAPI-stained nuclei (blue) are shown (right column). mNS
WT¼wild type, bar¼10 mm.
Table 1
Recombinant virus containing the mNS(78–79) mutation cannot be rescued via
reverse genetics. Titer of virus (PFU/ml) was obtained by counting plaques from
three experimental replicates with three technical replicates at each of three time
points following reverse genetics using either pT7–L2–M3–RZ(T1L) or pT7–L2–M3
(78–79)–RZ(T1L) and the remaining three plasmids from the MRV four-plasmid
reverse genetics set. TM¼too many plaques to count.
WT (78–79)
Experiment no. 1 96 h 540, 680, 680 0, 0, 0
72 h 140, 100, 90 0, 0, 0
48 h 10, 0, 30 0, 0, 0
Experiment no. 2 96 h 200, 270, 180 0, 0, 0
72 h 20, 20, 0 0, 0, 0
48 h 0, 10, 0 0, 0, 0
Experiment no. 3 96 h TM, TM, TM 0, 0, 0
72 h 370, 260, 80 0, 0, 0
48 h 210, 290, 200 0, 0, 0
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four plasmids were used in both the wild type and mutant experi-
ments. BHK-T7 cells were transfected with either the four wild type
plasmids (pT7–L1–M2T1L, pT7–L2–M3T1L, pT7–L3–S3T1L, and pT7–
M1–S1–S2–S4T1L), three wild type plasmids and pT7–L2–M3(78–
79)T1L, or the three wild type plasmids without pT7–L2–M3T1L as a
negative control. At 24, 48, 72, and 96 h p.t. cell lysates were collected
and standard MRV plaque assays were performed on L929 cells. In
three separate experiments we were unable to rescue mutant virus
containing the mNS(78–79) mutation while wild type virus was
rescued to varying levels in each replicate (Table 1).
To address the possibility that a virus containing the mNS(78–
79) mutation could exhibit delayed growth, six additional experi-
ments were performed in which cell lysates were collected at 3, 5,
and 7 days p.t. and the plaque assay procedure was modiﬁed to
allow for longer incubation. In every additional attempt wild type
virus was efﬁciently recovered but mutant virus was not (data not
shown). This indicates that mNS amino acids 78–79 are important
for successful de novo replication of MRV from reverse genetics
plasmids, either as a result of loss of localization with SGs, loss of
interaction with λ2, or for some other currently undeﬁned reason.
mNS(78–79) restores replication to near wildtype levels after M3
targeted siRNA knockdown
As we were unable to recover mutant virus using reverse
genetics we utilized a previously described alternate approach
(Arnold et al., 2008; Kobayashi et al., 2006) to assess the impor-
tance of mNS amino-acids 78–79 on MRV replication. In this
approach, an siRNA targeted to speciﬁc nucleotides (194–212) in
the T1L M3 gene was obtained commercially. Plasmids were then
created in which silent mutations were introduced into the siRNA
targeted area in either the wild type mNS (pT7M3RZ-si) or mutant
mNS(78–79) (pT7M3(78–79)RZ-si) background such that when
expressed, these M3 mRNAs would escape siRNA knockdown.
BHK-T7 cells were then transfected with T1L core particles, control
siRNA or M3 siRNA, and either pT7M3RZ-si or pT7M3(78–79)RZ-si.
Transfected cell lysates were collected at 24 and 48 h p.t. and viral
yields were determined by standard plaque assay on L929 cells. In
these experiments there was a 2-fold decrease in virus replication
in the presence of the M3 siRNA relative to the control siRNA at
both time points, indicating the M3 siRNA was knocking down
core-produced wild type M3 leading to inhibition of virus replica-
tion. Cotransfection of the wild type mNS expressing plasmid that
escapes M3 siRNA knockdown led to an 13-fold (24 h p.i.) and 10-fold
(48 h p.i.) increase in virus replication relative to the samples with the
M3 siRNA alone, suggesting that wild type mNS protein can rescue
virus replication to levels even higher than those seen by cores in the
control siRNA samples. Interestingly, cotransfection of mNS(78–79)
was also able to rescue virus replication to similar levels (7-fold, 24 h
p.i. and 9-fold, 48 h p.i.), although the rescue was somewhat less
efﬁcient and slower thanwild type (Fig. 7A). The relative levels of mNS
protein expression in these experiments were conﬁrmed with immu-
noblots against mNS (Fig. 7B). These results, when considered in light
of our inability to rescue mutant virus with reverse genetics, suggest
that while the mutant mNS(78–79) is unable to support de novo virus
replication, it is able to contribute positively to viral replication in the
presence of low levels of wild type mNS produced by cores that escape
siRNA knockdown in these experiments.
Discussion
In this work we have shown that MRV protein mNS localizes
with SGs in infected and transfected cells but that it is not capable
Fig. 7. mNS(78–79) is able to rescue MRV replication following siRNA knockdown of M3. (A) BHK-T7 cells were transfected with cores (all lanes), control siRNA (lanes 1 and
5), M3 siRNA (lanes 2–4 and 6–8), and pT7M3RZ-si (lanes 3 and 7) or pT7M3(78–79)RZ-si (lanes 4 and 8). Cell lysates were collected at 24 h p.t. (lanes 1–4) and 48 h p.t.
(lanes 5–8) and used for plaque assays (A) and immunoblot analysis (B). Samples were adjusted relative to the coresþM3 siRNA sample (lanes 2 and 6) and the relative
numbers were averaged from three experimental replicates with standard error of the averaged samples shown.
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of inducing or disrupting SGs in the absence of infection. None-
theless, we sought to characterize this localization as both a
potentially important step in MRV modulation of SGs during
infection and to determine whether this interaction is necessary
for viral replication. In the course of our studies we identiﬁed mNS
amino-acids 78 and 79 as being necessary for mNS localization to
SGs. When this mNS mutant was used in attempts to recover virus
using reverse genetics, no viable virus was recovered, indicating
that these amino acids play a necessary role in de novo MRV
replication from reverse genetics plasmids. Additional rescue
experiments using siRNA showed that the presence of low levels
of wild type mNS in combination with mutant mNS(78–79) is able
to rescue viral replication from M3 knockdown. In our investiga-
tion of the functionality of the mNS(78–79) mutant, we also found
that it lost interaction with the virus core protein λ2. mNS
recruitment of λ2 to VFs during infection likely is also a critical
function of the protein. Therefore, while this region of mNS appears
to be vital for successful de novo MRV replication, it is difﬁcult to
ascertain whether it is the loss of SG localization, λ2 association, or
both that render the mutant non-viable in recovery of recombi-
nant virus. Moreover, the inability to rescue recombinant mutant
virus prevents further investigation that may determine if the mNS
(78–79) mutant is defective in SG modulation or λ2 recruitment to
VFs in infected cells. Although it is clear that these amino-acids are
important for virus replication, without being able to separate the
phenotypes of loss of mNS localization to SGs from loss of the λ2-
mNS interaction it is unlikely that we will be able to use this
mutant to elucidate the role that localization between mNS and SGs
plays in viral replication.
Although amino acids 78–79 of mNS are necessary for localiza-
tion with SGs, it remains unknown how and under what circum-
stances mNS interacts with SGs in infected cells. Some previous
evidence suggests that mNS is capable of binding viral ss and
dsRNA (Antczak and Joklik, 1992). Considering SGs are made up of
numerous RNA-binding proteins, it is possible that the mNS
interaction with SGs occurs indirectly through binding of the same
RNA by both an SG localized protein and mNS. As the localization of
mNS to SGs occurs in both infected and transfected cells expressing
the mNS encoding M3 RNA, it may be possible that mNS is recruited
to SGs indirectly, but speciﬁcally through a viral RNA interaction or
non-speciﬁcally via non-speciﬁc RNA interactions. In addition, λ2
which functions as the guanylyl- and methyl-transferase for
reovirus mRNAs (Luongo et al., 2000) may be associated with
mNS through an indirect RNA intermediate, and mutation of mNS
amino-acids 78–79 may destroy the ability of mNS to associate
with RNA, thereby disrupting mNS interaction with both SGs and
λ2. Additional experiments will be necessary to determine the
RNA-binding capacity of this mNS mutant and the relationship
between mNS RNA binding and SG and λ2 association.
It is also possible that mNS amino-acids 78 and 79 interact
directly with a SG-localized protein. It is clear from our studies
that the proteins most often associated with SG formation (TIAR,
TIA-1, and G3BP) are not involved in this interaction as when mNS
is expressed alone in cells, these proteins do not colocalize with
VFLs (Fig. 1 and data not shown). Translation initiation factors and
other cellular proteins that localize to SGs are additional possible
recruitment proteins. It would seem sterically difﬁcult for both λ2
and an as of yet unidentiﬁed SG protein to interact with a single
mNS molecule at these residues simultaneously. However, it is
possible that both interactions occur but at different times during
infection or through independent interaction of different mNS
molecules with either SGs or λ2. Our siRNA knockdown results
may lend support to the idea that separate mNS molecules interact
with different MRV proteins as the mutant mNS(78–79) was
clearly unable to support de novo replication but when present
in core-transfected cells expressing wild type mNS, the mutant was
able to support replication at levels similar to cells transfected
with wild type mNS. What is evident from our work thus far is that
mNS does not require any other virus proteins for localization to
SGs as it is found in SA-induced SGs in the absence of infection.
We have now shown that parental core particles as well as mNS
are localized to SGs at early times in infection (Qin et al., 2009).
This localization could be a strategy of the virus to increase viral
replication as effective translation appears to be correlated with
MRV disruption of SGs (Qin et al., 2011). If MRV cores localize to
SGs, it would put them in a good location to co-opt the seques-
tered translation factors in SGs. By appropriating the translation
factors found in SGs, MRV mRNAs could presumably be translated
more efﬁciently than if each mRNA needed to ﬁnd each transla-
tional regulatory component separately. This colocalization may
also have a nucleating effect for VFs, with viral translation
occurring near SGs resulting in the genesis of new VFs consisting
of mNS and other viral proteins. Much additional work will need to
be performed to understand the relationship between SGs and
MRV VFs.
Many other viruses have been shown to interact with SGs in
infected cells in order to replicate effectively (Lloyd, 2012).
Although the mechanisms used by other viruses to interact with
the SG pathway vary greatly, it is clear that viral evasion and/or
viral subversion of this pathway is an important part of the
lifecycle of many viruses. While in most cases SGs are seen as a
barrier to productive infection, the formation of SGs could prove
beneﬁcial in a viral infection if their presence also prevents host
translation or their formation results in a convenient accumulation
of cellular translational components for virus usage. In a situation
in which SG formation is beneﬁcial, it is likely that the virus will
need a way to disrupt these SGs or “pull” the necessary compo-
nents from SGs. In MRV it appears that mNS could function in that
capacity but more research is needed to show if this is truly
the case.
Methods
Cells and reagents
Cos-7 cells were maintained in Dulbecco's Modiﬁed Eagle's
Medium (DMEM) (Invitrogen Life Technologies) containing 10%
fetal bovine serum (Atlanta Biologicals) and penicillin–streptomy-
cin (100 IU/ml; Mediatech). BHK-T7 cells (Buchholz et al., 1999)
were maintained in Dulbecco's Modiﬁed Eagle's Medium (DMEM)
(Sigma) containing 10% fetal bovine serum, penicillin–streptomycin
(100 IU/ml), L-Glutamine (2 nM; Mediatech), Non-Essential Amino
Acids (Invitrogen Life Technologies), and Fungazone (25 ng/ml;
Invitrogen) with 1 mg/ml of G418 (Alexis Biochemical) added every
other passage to maintain the T7 polymerase. L929 cells were
maintained in Minimum Essential Medium with Joklik Modiﬁcation
(Sigma) containing 5% fetal bovine serum, 5% bovine calf serum
(HyClone Laboratories), penicillin–streptomycin (100 IU/ml), and L-
Glutamine (4 nM). The commercial primary antibodies used in
immunoﬂuorescence assays were as follows: goat polyclonal anti-
TIAR (α-TIAR) antibody (sc-1749; Santa Cruz Biotechnology) and
mouse monoclonal anti-multi-ubiquitin antibody (D071-3; Medical
& Biological Laboratories Co., LTD). Rabbit polyclonal antiserum
against mNS, rabbit polyclonal antiserum against MRV-core, rabbit
polyclonal antiserum against m2, rabbit polyclonal antiserum against
sNS, and mouse monoclonal antibody (7F4) against λ2 have been
previously described (Broering et al., 2000, 2002; Gillian and Nibert,
1998; Virgin et al., 1991). The mouse polyclonal antiserum (174)
against mNS was created at the Iowa State University Hybridoma
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Facility using peptides against mNS amino acids 178–197 and 282–
301 synthesized using a Multiple Antigen Peptide System. The
secondary antibodies used in immunoﬂuorescence experiments
were as follows: Alexa 488- or Alexa 594-conjugated donkey
α-mouse, α-rabbit, or α-goat IgG antibodies (Invitrogen). Primary
antibodies used in immunoblots were rabbit polyclonal antiserum
against mNS and anti-β-actin antibody (Cell Signaling #4967). The
secondary antibody used was goat α-rabbit AP conjugate (Bio-Rad).
Sodium arsenite (SA) (Sigma-Aldrich) was used where indicated at a
ﬁnal concentration of 0.5 mM. Cycloheximide (Sigma-Aldrich) was
used where indicated at a ﬁnal concentration of 100 μg/ml.
Viruses
Viral preps were grown in six, ﬁve layer multi-ﬂasks (BD Falcon
#353144) that were each seeded with at least 7106 L929 cells
and 35 ml of media per layer. Flasks were incubated at 37 1C until
conﬂuent at which point they were infected with a pfu of 5 in
50 ml of fresh media. Flasks were incubated for 1 h at room temp
with the virus/media solution being mixed via the mixing port
every 10–15 min. Fresh media was added back to the ﬂask and
ﬂasks were incubated at 37 1C until 80% cell death was observed.
Virus was collected by centrifugation of media and cell debris at
3000g for 10 min in 225 ml tubes (BD Falcon #352075). Cell pellets
were resuspended in a total of 8 ml HO buffer (250 nM NaCl,
10 mM Tris, pH 7.4), combined, and frozen at 80 1C. T3DC virions
were puriﬁed as described previously (Mendez et al., 2000), using
Vertrel reagent (DuPont) in place of Freon and stored in dialysis
buffer (150 mM NaCl,10 mM Tris, pH 7.4, 10 mM MgCl2) at 4 1C.
The superscript C in T3DC is used to differentiate the T3D strain
used in this study from a T3D strain (T3DN/T3DF) that has
previously been shown to differ in M1 gene sequence, factory
morphology, and μ2 ubiquitination phenotype (Miller et al., 2004).
We refer to the virus as T3D throughout the manuscript. Viral
titers (CIU) were determined on Cos-7 cells as previously
described (Qin et al., 2011). Plaque assays were performed in
6 well dishes seeded with 1.2106 L929 cells per well 24 h prior
to infection and overlay. For reverse genetics experiments, cells
were overlaid with 100 ml of cell lysate and incubated for 1 h at
room temp with shaking every 10–15 min. For the initial three
reverse genetics experiments (Table 1), 3 ml of equal parts 2%
Bacto-Agar (BD) in H2O and 2X199 (Sigma) mixture with 10 ng/ml
Trypsin (Worthington) was immediately overlaid on the L929
monolayer following incubation. For the six additional reverse
genetics experiments, infected monolayers were incubated with
fresh media at 37 1C for at least 1 h before agar overlay. This
treatment resulted in increased time to visualize plaques before
complete cell death and was utilized to compensate for potential
decreases in replication kinetics of mutant virus. For the siRNA
plaque assays cell lysates were serially diluted and 100 ml of each
dilution was incubated on the cells for 1 h at room temp with
shaking every 10–15 min prior to agar overlay.
Plasmid creation
Clones (all T1L) pCI–mNS, pCI–mNS(55–721), pCI–mNS(65–721),
pCI–mNS(75–721), pCI–mNS(85–721), pCI–mNS(95–721), pCI–sNS,
pCI–s2, pCI–m2, pCI–λ1, and pCI–λ2 were described previously
although pCI–mNS, pCI–sNS, pCI–s2, pCI–m2, pCI–λ1, and pCI–λ2
were referred to by their gene names (Broering et al., 2004, 2002;
Miller et al., 2010, 2003; Parker et al., 2002). Parent plasmid
pCIM3RZ was created by amplifying the viral M3 gene from
puriﬁed dsRNA (T1L) using primers containing a SacI site and
minimal CMV promoter upstream from the M3 5' end and a SmaI
site after the 3' end. The PCR product was digested and ligated into
SacI/SmaI sites upstream from a self-cleaving hepatitis δ ribozyme.
pT7M3RZ was created by performing PCR on pCIM3RZ using a
primer with a SacI site and T7 promoter upstream from the 5' end
of M3 and a primer with a AvaI site at the 3' end of M3. The PCR
product was puriﬁed and ligated into pCIM3RZ cut with SacI and
AvaI. Mutants pT7–mNS(76–79)RZ and pT7–mNS(80–84)RZ were
created by overlap PCR using primers containing nucleotide
mutations resulting in four or ﬁve amino-acid changes within
mNS (pCI–mNS(76–79); LVVR-AGAG, pCI–mNS(80–84); PFSSG-
AGAAG) and the vector pT7M3RZ as template. PCR products were
digested with NruI and SpeI and ligated into EcoRV and SpeI
digested pBluescriptIIKS(). Using SpeI and BclI restriction sites
the respective mutations were each ligated into pT7M3RZ.
Mutants pT7–mNS(76–77)RZ (LV-AG), pT7–mNS(78–79)RZ (VR-
AG), pT7–mNS(78)RZ (V-A), and pT7–mNS(79)RZ (R-G) were
created by overlap PCR using primers containing the indicated
mutations and pT7–mNS(76–79)RZ as template. The PCR products
and vector pT7–mNS(76–79)RZ were then digested with SpeI and
BclI and ligated. Mutant pT7–μNS(78–79, VR-LK)RZ was created
using a gBlock (Integrated DNA Technologies) containing the
desired mutations and BbvCI and PciI restriction sites. pT7–NS
(78–79)RZ and the gBlock were digested with BbvCI and PciI, and
ligated. The reverse genetics mutant pT7–L2–M3(78–79)–RZ(T1L)
was created by digestion of pT7–mNS(78–79)RZ and pT7–L2–M3–
RZ(T1L) (Kobayashi et al., 2010) with PshAI and AgeI and ligation
of the digested mutant fragment into the digested reverse genetics
plasmid. The wild type (pT7M3RZ-si) and mutant (pT7M3(78–79)
RZ-si) plasmids used in the siRNA knockdown experiments were
modiﬁed from pT7M3RZ–T1L and pT7–mNS(78–79)RZ to contain
three silent mutations in the siRNA recognition sequence by using
PCR primers containing the mutations and restriction sites EcoNI
and AvaI to insert the PCR product into the parent plasmids. All
plasmids were positively selected by restriction enzyme digest and
conﬁrmed by nucleotide sequencing. Primer sequences are avail-
able on request.
Transfections and infections
Cos-7 cells were seeded onto 6-well cell culture plates at
1.5105 per well containing 18 mm diameter coverslips the day
before transfection/infection. To infect samples, media was
removed from cells and T3DC at a CIU of 1 was diluted into
phosphate buffered saline (PBS) [137 mM NaCl, 3 mM KCl, 8 mM
Na2HPO4 (pH 7.5)] containing 2 mM MgCl2 and adsorbed to cells
for 1 h, after which cells were overlaid with DMEM and incubated
at 37 1C. To transfect cells 2.5 mg (one plasmid) or 2 mg (two
plasmids) of plasmid DNA and 3 ml of Trans-IT LT1 per mg of DNA
were combined in 250 ml of Optimem media (Invitrogen Life
Technologies), incubated for 20 min at room temp, and added to
cell media. Cells were then incubated at 37 1C for 16–24 h and
subjected to downstream assays.
Immunoﬂuorescence assay
Cells were washed once with PBS and ﬁxed at room tempera-
ture for 15 min with 4% paraformaldehyde in PBS. Fixed cells were
washed three times with PBS, permeabilized by incubation with
0.2% Triton X-100 in PBS for 5 min, and then washed three times
with PBS. Samples were blocked by a 5-min incubation with 2%
bovine serum albumin (BSA) in PBS. Primary and secondary
antibodies were diluted in 2% BSA in PBS. After blocking cells
were incubated for 30 min with primary antibodies, washed three
times with PBS, and then incubated for an additional 30 min with
secondary antibodies. Cells were washed a ﬁnal three times with
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PBS and mounted on slides with Prolong reagent with DAPI (4,6-
diamidino-2-phenylindole dihydrochloride) (Invitrogen). Samples
were examined and images acquired with a Zeiss Axiovert 200
inverted microscope equipped with ﬂuorescence optics. Images
were prepared using Photoshop and Illustrator software (Adobe
Systems).
Immunoblot assay
Cell lysates in protein loading buffer were separated by sodium
dodecyl sulfate polyacrylamide electrophoresis (SDS-PAGE) and
transferred to nitrocellulose by electroblotting in transfer buffer
(25 mM Tris, 192 mM Glycine, 15% Methanol [pH 8.3]). Nitrocellu-
lose membranes were blocked in 5% BSA in PBS for 20 min and
then primary antibodies were diluted in 5% BSA in PBS, added to
membranes, and incubated overnight on a rocker at 4 1C. Blots
were then washed 3 times for 10 min with Tris buffered saline
with Tween 20 (TBS-T; 20 mM Tris, 137 mM NaCl, 0.5% Tween-20,
[pH 7.6]). After washing, AP conjugated secondary antibodies were
incubated with the blots in 5% BSA in PBS for 4 h at room
temperature. Blots were washed another 3 times with TBS-T and
were exposed using a chemiluminescent substrate Lumi-Phos™
(Thermo Scientiﬁc). Images were acquired and protein levels
quantiﬁed using a Chemi-doc XRS camera and Quantity One
software (Bio-Rad).
MRV reverse genetics
The reverse genetics transfection protocol was modiﬁed from
Kobayashi et al. (2010). 4105 BHK-T7 cells were seeded onto 6-
well plates and transfected with 2 mg each of speciﬁed reverse
genetics plasmids in 340 ml of Optimem using 3 ml of Trans-IT LT1
per mg of DNA. In some experiments (Table 1) sample lysates were
collected by two freeze-thaw cycles at 48, 72, or 96 h p.t. and
plaque assays were performed as previously described. In other
experiments (data not shown), samples were collected at 3, 5, or
7 days p.t. to compensate for potential decreases in replication
kinetics of mutant virus prior to plaque assay.
siRNA and siRNA Transfections
Control siRNA (Thermo; ON-TARGETplus Non-targeting siRNA
#1) and M3-si01 (Thermo; 5'-UACCUUAUCAGCAUGUGAAdTdT-3')
(Arnold et al., 2008) siRNA were acquired commercially and
resuspended to a concentration of 40 mM. 17.5 ml (ﬁnal concentra-
tion of 100 nM) of each siRNA, 11010 T1L viral cores, and 5 mg
plasmid DNA were mixed with 15 ml Trans-IT LT1 and 500 ml
Optimem and incubated for 20 min at room temperature and then
added to 60 mm dishes seeded with BHK-T7 cells the previous day
at a concentration of 9.5105. Dishes were incubated at 37 1C for
24 or 48 h and then either harvested into 100 ml of protein loading
buffer for immunoblot analysis or subjected to two freeze/thaw
cycles in preparation for plaque assays.
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